INR 130.85 CHEMOPH.BO Chemo Pharma (BSE) 26 Feb 2026: oversold bounce watch
We saw a strong intraday recovery in CHEMOPH.BO stock on 26 Feb 2026, closing at INR 130.85 on the BSE after touching a session low of INR 115.00. The jump of INR 24.62 on the day and relative volume at 1.49x versus average suggests a short-term oversold bounce. We view this as a tactical rebound, not a trend reversal. Traders should watch immediate resistance and the company’s fundamentals before adding size.
Price action & session recap (CHEMOPH.BO stock)
CHEMOPH.BO stock closed the market session (Market Closed) at INR 130.85 on 26 Feb 2026. The stock opened at INR 116.00, hit a low of INR 115.00, and a high of INR 134.95. Volume was 766.00 shares versus an average of 513.00, giving a relative volume of 1.49. The one-day change measured INR 24.62, a clear intraday bounce from oversold levels.
Why the oversold bounce is likely (CHEMOPH.BO stock setup)
The bounce follows a sharp move lower into the year low area and a long 1D recovery. Price is above the 50-day average of INR 119.95 and above the 200-day average of INR 117.99, supporting short-term mean reversion. Sector flows into Healthcare show muted performance YTD, so isolated stock moves like this can produce tactical bounces.
Financial and valuation snapshot (CHEMOPH.BO stock financials)
Chemo Pharma Laboratories Limited shows a market cap of INR 196,275,000.00 and shares outstanding 1,500,000.00. Key metrics include EPS -81.48, PE -1.61, book value per share INR 87.63, and price-to-book 1.49. Revenue per share TTM is 2.26 and gross margin is extremely high at 99.35%, while net margin is negative at -34.56%. These mixed fundamentals support a cautious, tactical trade rather than long-term conviction.
Technical levels and trading plan (CHEMOPH.BO stock technicals)
Key support sits near the session low INR 115.00 and the Keltner middle at INR 114.90. Immediate resistance aligns with the day high INR 134.95 and the quarterly model near INR 144.37. A disciplined entry for an oversold bounce: buy a partial position above INR 122.00, add on break of INR 135.00, stop loss below INR 112.00. Target the near-term projection of INR 144.37 for a tactical 10.33% upside.
Meyka grade and forecast (CHEMOPH.BO stock rating & forecast)
Meyka AI rates CHEMOPH.BO with a score out of 100 and assigns a Score: 66.66 | Grade: B | Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects Quarterly: INR 144.37 and Yearly: INR 182.48. Compared with the current price INR 130.85, the quarterly implied upside is 10.33% and the yearly upside is 39.47%. Forecasts are model-based projections and not guarantees.
Risks and catalysts (CHEMOPH.BO stock risks & opportunities)
Primary risks include negative EPS (-81.48) and a history of operating losses reflected in margins. Low free cash flow metrics and limited liquidity increase execution risk for large orders. Catalysts that could extend the bounce: positive earnings updates, corporate action on business shift to power and chemicals, or sector rotation into Healthcare. Monitor volume and any company announcements.
Final Thoughts
CHEMOPH.BO stock closed the BSE session at INR 130.85 on 26 Feb 2026 after a decisive intraday recovery from INR 115.00. The move shows a classic oversold bounce pattern, supported by higher relative volume and price trading above the 50-day and 200-day averages. Our short-term outlook is tactical: a near-term price target of INR 144.37 gives an implied upside of 10.33%, while Meyka AI’s one-year model at INR 182.48 implies 39.47% upside. Risk remains elevated due to negative EPS and thin liquidity, so use tight stops and size positions conservatively. For those using a bounce strategy, consider scaling in above INR 122.00, trimming into strength near INR 144.37, and keeping a stop near INR 112.00. These are model-guided figures and not investment advice. For live updates and screening, see our coverage on the Meyka AI platform and the company site Chemo Pharma Laboratories Limited. Additional company data sourced from Financial Modeling Prep profile image source.
FAQs
Is CHEMOPH.BO stock in a buyable oversold bounce setup now?
Yes, the intraday rebound to INR 130.85 on 26 Feb 2026 suggests a tactical oversold bounce. Consider a scaled entry above INR 122.00, target INR 144.37, and use a stop below INR 112.00. Adjust size for liquidity and risk.
What are the key valuation metrics for CHEMOPH.BO stock?
Key metrics: market cap INR 196,275,000.00, EPS -81.48, PE -1.61, book value INR 87.63, and price-to-book 1.49. These show mixed valuation and require cautious interpretation.
What does Meyka AI forecast for CHEMOPH.BO stock?
Meyka AI’s forecast model projects a quarterly level of INR 144.37 and a yearly level of INR 182.48. The quarterly upside from INR 130.85 is 10.33%. Forecasts are model-based projections and not guarantees.
What are the main risks to an oversold bounce trade in CHEMOPH.BO stock?
Main risks: negative earnings, thin liquidity (volume 766.00), and margins under pressure. Large orders can move price. Use tight stops, small position sizes, and watch company announcements.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.